Histogen

Histogen Begins Clinical Trial for Female Hair Loss

Growth factors for female hair loss

Histogen, a regenerative medicine company focused on stimulating the body’s stem cells to regenerate tissues and restore youthful function, has launched a Phase I Clinical Trial of its lead product, Hair Stimulating Complex, to treat female diffuse hair loss. Principal investigator Kimberly Butterwick, MD, is actively recruiting and enrolling trial participants following U.S. Food and Drug Administration (FDA) approval of the company’s Investigational New Drug (IND) application last month.

Allergan Acquires Regenica Line With Plans To Expand Histogen Growth Factor Technology

Growth Factor-Based Skin Care

Allergan has acquired the Regenica growth factor-based skincare line, and will market the line’s proprietary multipotent cell-conditioned media, which was developed by regenerative medicine company Histogen. Allergan plans to incorporate the technology, known as Multipotent Resignaling Complex (MRCx), in future products under the SkinMedica portfolio.